Lithium carbonate in the management of cannabis withdrawal: a randomized placebo-controlled trial in an inpatient setting (Q52304772)

29 April 2018

http://europepmc.org/abstract/MED/24880749

title

Lithium carbonate in the management of cannabis withdrawal: a randomized placebo-controlled trial in an inpatient setting (English)

1 reference

29 April 2018

http://europepmc.org/abstract/MED/24880749

1 reference

placebo-controlled trial

1 reference

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24880749 AND SRC:MED&resulttype=core&format=json

5 June 2020

Iain McGregor

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24880749 AND SRC:MED&resulttype=core&format=json

5 June 2020

author name string

Jennifer Johnston

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24880749 AND SRC:MED&resulttype=core&format=json

5 June 2020

Nicholas Lintzeris

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24880749 AND SRC:MED&resulttype=core&format=json

5 June 2020

David J Allsop

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24880749 AND SRC:MED&resulttype=core&format=json

5 June 2020

Jessica Booth

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24880749 AND SRC:MED&resulttype=core&format=json

5 June 2020

Dean S Carson

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24880749 AND SRC:MED&resulttype=core&format=json

5 June 2020

David Helliwell

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24880749 AND SRC:MED&resulttype=core&format=json

5 June 2020

Adam Winstock

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24880749 AND SRC:MED&resulttype=core&format=json

5 June 2020

publication date

1 June 2014

1 reference

29 April 2018

http://europepmc.org/abstract/MED/24880749

number of pages

14

1 reference

inferred from page(s)

published in

Psychopharmacology

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24880749 AND SRC:MED&resulttype=core&format=json

5 June 2020

volume

231

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24880749 AND SRC:MED&resulttype=core&format=json

5 June 2020

issue

24

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24880749 AND SRC:MED&resulttype=core&format=json

5 June 2020

page(s)

4623-4636

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24880749 AND SRC:MED&resulttype=core&format=json

The Cannabis Withdrawal Scale development: patterns and predictors of cannabis withdrawal and distress

5 June 2020

cites work

1 reference

https://api.crossref.org/works/10.1007/S00213-014-3611-5

Quantifying the clinical significance of cannabis withdrawal

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00213-014-3611-5

Changes in cigarette and alcohol use during cannabis abstinence.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00213-014-3611-5

Nabiximols as an agonist replacement therapy during cannabis withdrawal: a randomized clinical trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00213-014-3611-5

Impact of prolonged cannabinoid excretion in chronic daily cannabis smokers' blood on per se drugged driving laws

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00213-014-3611-5

The time course and significance of cannabis withdrawal

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00213-014-3611-5

Cannabis use disorder: epidemiology and management

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00213-014-3611-5

The Cannabis Problems Questionnaire: factor structure, reliability, and validity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00213-014-3611-5

Cannabis withdrawal among non-treatment-seeking adult cannabis users

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00213-014-3611-5

State of the art treatments for cannabis dependence

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00213-014-3611-5

Lithium: updated human knowledge using an evidence-based approach: part III: clinical safety

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00213-014-3611-5

Cannabis withdrawal in the United States: results from NESARC.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00213-014-3611-5

Plasma oxytocin and vasopressin do not predict neuropeptide concentrations in human cerebrospinal fluid.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00213-014-3611-5

Implications of plasma Delta9-tetrahydrocannabinol, 11-hydroxy-THC, and 11-nor-9-carboxy-THC concentrations in chronic cannabis smokers

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00213-014-3611-5

A randomized double-blind, placebo-controlled trial of venlafaxine-extended release for co-occurring cannabis dependence and depressive disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00213-014-3611-5

Assessing Response Profiles from Incomplete Longitudinal Clinical Trial Data Under Regulatory Considerations

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00213-014-3611-5

The Severity of Dependence Scale (SDS) in an adolescent population of cannabis users: reliability, validity and diagnostic cut-off.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00213-014-3611-5

A proof-of-concept randomized controlled study of gabapentin: effects on cannabis use, withdrawal and executive function deficits in cannabis-dependent adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00213-014-3611-5

Problems with measuring peripheral oxytocin: can the data on oxytocin and human behavior be trusted?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00213-014-3611-5

Breaking the loop: oxytocin as a potential treatment for drug addiction.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00213-014-3611-5

From ultrasocial to antisocial: a role for oxytocin in the acute reinforcing effects and long-term adverse consequences of drug use?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00213-014-3611-5

A placebo-controlled trial of buspirone for the treatment of marijuana dependence

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00213-014-3611-5

Effect of oxytocin on craving and stress response in marijuana-dependent individuals: a pilot study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00213-014-3611-5

Intranasal oxytocin blocks alcohol withdrawal in human subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00213-014-3611-5

Cannabis withdrawal severity and short-term course among cannabis-dependent adolescent and young adult inpatients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00213-014-3611-5

Neurocognitive performance during acute THC intoxication in heavy and occasional cannabis users

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00213-014-3611-5

Inference and missing data

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00213-014-3611-5

Development of the Alcohol Use Disorders Identification Test (AUDIT): WHO Collaborative Project on Early Detection of Persons with Harmful Alcohol Consumption--II

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00213-014-3611-5

Multiple imputation: a primer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00213-014-3611-5

Evaluation of Enzyme Immunoassay and Radioimmunoassay Methods for the Measurement of Plasma Oxytocin

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00213-014-3611-5

Pharmacological Treatment of Cannabis Dependence

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00213-014-3611-5

Lithium carbonate in the management of cannabis withdrawal in humans: an open-label study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00213-014-3611-5

Effects of GSK3 inhibitors on in vitro expansion and differentiation of human adipose-derived stem cells into adipocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00213-014-3611-5

Preliminary evidence for lowered basal cortisol in a naturalistic sample of methamphetamine polydrug users

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00213-014-3611-5

Ultra sensitive quantitation of endogenous oxytocin in rat and human plasma using a two-dimensional liquid chromatography-tandem mass spectrometry assay

21 January 2018

1 reference

12 December 2020

Clinical pharmacodynamics and pharmacokinetics of antimanic and mood-stabilizing medications

1 reference

12 December 2020

Practical and statistical issues in missing data for longitudinal patient-reported outcomes

1 reference

12 December 2020

Prevention of cannabinoid withdrawal syndrome by lithium: involvement of oxytocinergic neuronal activation.

1 reference

12 December 2020

Nabilone decreases marijuana withdrawal and a laboratory measure of marijuana relapse

1 reference

12 December 2020

Dissociation by lithium of hormone-induced formation of cyclic AMP and release of glycerol in isolated rat fat cells

1 reference

12 December 2020

The Severity of Dependence Scale (SDS): psychometric properties of the SDS in English and Australian samples of heroin, cocaine and amphetamine users.

1 reference

12 December 2020

Lithium and marijuana withdrawal

1 reference

12 December 2020

10.1007/S00213-014-3611-5

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24880749 AND SRC:MED&resulttype=core&format=json

5 June 2020

1 reference